Post de Gustave Roussy

#BreastCancer | 𝗡𝗼𝘃𝗲𝗹 𝗟𝗶𝗻𝗸 𝗯𝗲𝘁𝘄𝗲𝗲𝗻 𝗜𝗻𝗳𝗹𝗮𝗺𝗺𝗮𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗠𝗲𝘁𝗮𝘀𝘁𝗮𝘀𝗶𝘀 𝗶𝗻 𝗕𝗿𝗲𝗮𝘀𝘁 𝗖𝗮𝗻𝗰𝗲𝗿 | A remarkable breakthrough in breast cancer research has been unveiled by an international team led by Prof. Dr. Curzio Ruegg from the Université de Fribourg - Universität Freiburg. The team, involving researchers from the University of Helsinki, University of Lausanne, and the SIB Swiss Institute of Bioinformatics at the CHUV | Lausanne university hospital, has discovered a new mechanism that links inflammation and breast cancer metastasis. Delving into the role of granulocytes in the formation of metastases, the team identified a novel sequence involving the production of oncostatin and interleukin 6. This research is imperative for cancer treatment as it may provide new horizons for modulating inflammation and devising targeted therapeutics for patients at high risk of metastases. The uncovered genetic signature can help pinpoint patients potentially threatened by metastatic disease, supporting the advancement of personalized cancer treatments. 👉 Learn more >> https://lnkd.in/gdmarW6H 👉 Original publication >> https://lnkd.in/gbXkyqyT 🇨🇭 Follow #ScienceSwitzerland for the latest news and emerging trends on Swiss science, technology, education, and innovation >> www.swissinnovation.org Follow us >> Science-Switzerland #Science | #Education | #Research | #Innovation

quelles avancées !

🚀 Télésurveillance en Oncologie : Des Résultats Prometteurs 🚀 Découvrez comment la télésurveillance révolutionne la prise en charge des patients atteints de cancer ! 🔬🩺 Une étude multicentrique, récemment publiée dans The Lancet Regional Health – Europe, explore l'impact d'un suivi numérique à distance sur la gestion des symptômes chez plus de 3000 patients en France et en Belgique. 🌍 🎯 Points clés : - Réduction significative des symptômes : 94,6% des alertes graves ont conduit à une amélioration en deux semaines. - Amélioration de la qualité de vie : 88,4% des patients ont observé une nette amélioration de leurs symptômes. - Intervention rapide : Réponse en moins de 14 heures par l'équipe soignante. - Adhésion élevée : 82% des patients ont participé régulièrement. 👩⚕️ Selon la Dr Maria Alice Franzoi de Gustave Roussy : "Cette étude montre que la télésurveillance permet d'identifier les symptômes avant qu'ils ne s'aggravent, évitant ainsi les urgences et hospitalisations." 🔗 https://lnkd.in/dtR33yn4 #Oncologie #Télésurveillance #InnovationSanté #Cancer #RechercheMédicale #SantéNumérique #GustaveRoussy #LeMondePharmaceutique

Choosing a private gynaecologist for cancer tests and diagnosis   Waiting for a gynaecological cancer test is certain to be a worrying time for most women. Choosing a private gynaecologist such as Lancashire Gynaecologist can provide a level of personalised care that goes above and beyond. With shorter wait times than the NHS for appointments and tests, you'll have timely access to screenings and consultations, crucial for early detection and treatment. Additionally, we often emphasise open communication, empowering you to ask questions, discuss concerns, and actively participate in your healthcare decisions. By investing in advanced technologies and diagnostic tools, we can ensure the accuracy and efficiency of cancer testing. Moreover, the confidential and comfortable setting of a private practice such as ours offers a more discreet and respectful experience during examinations and screenings. For more information or to book an appointment go to https://lnkd.in/dQ_H5sep #cancerawareness

CYBERJAYA, Malaysia - The Malaysian Ministry of Health addressed concerns regarding the waiting period for cancer patients receiving treatment at public hospitals during the launch of World Cancer Day 2024 at the University of Cyberjaya. Health Minister Datuk Seri Dr. Dzulkefly Ahmad emphasized that the waiting time depends on various factors, including the urgency of the case, and assured that immediate treatment is provided when necessary. Acknowledging the challenge of long waiting times at public hospitals, Dzulkefly stated that cancer patients who are diagnosed during screenings are referred to general hospitals for treatment by family medical specialists at public health clinics. To further strengthen cancer treatment facilities in the country, the ministry collaborates with teaching hospitals under the Higher Education Ministry, in addition to cooperating with private hospitals. Health Director-General Datuk Dr. Muhammad Radzi Abu Hassan clarified that cancer patients can receive immediate treatment as early as the next day after receiving their screening results, depending on the severity and urgency of the case. He emphasized that there should not be any significant issue regarding long waiting times for treatment, as the ministry's services aim to reach the community at every level. The Malaysian Cancer Registry reported 168,822 cancer cases between 2017 and 2021, but Dzulkefly affirmed that existing facilities at public hospitals can still manage the increasing number of cases. The ministry remains committed to improving cancer treatment accessibility and providing quality care to all patients in Malaysia. Source: https://lnkd.in/gcN7EJ4p Date: February 17, 2024 #AdipoLABs #Hyperthermia #CancerCare #WorldCancerDay #CancerTreatment #PainBot #PainManagement #Physiotherapy #SportInjury #MedicalDevice #PainRelief #Pain #PainDetection #PainTreatment #Physiotherapist #Research #Innovation

En direct, la session sur : Fistule génitale, Cancers gynéco-mammaires. https://lnkd.in/dwtWTRAf

1er centre européen de lutte contre le cancer, 4ème meilleur hôpital de cancérologie au monde selon le magazine Newsweek, Gustave Roussy est un institut de soins, de recherche et d'enseignement, qui prend en charge des patients atteints de tout type de cancer, à tout âge de la vie. Son expertise des #cancers rares et des tumeurs complexes est internationalement reconnue. Gustave Roussy réunit excellences médicale, scientifique et technologique au service du traitement des patients. Ses experts de renommée internationale se mobilisent pour mener à bien les trois missions de l’Institut : les soins, la recherche et l’enseignement. Ils portent l’ambition de guérir le cancer au 21e siècle. #JourneeMondialeContreLeCancer

World Gynaecologic Oncology Day is this Friday 20 September 🌍 Each year, more than 1 million women globally are diagnosed with a gynaecologic cancer, a set of cancers originating in the reproductive organs. However, due to the tumour location and nature of the symptoms and treatments, gynaecologic cancer patients can run up against societal stigmas. On Friday, more than 100 awareness activities are forecast around the world with a shared goal of combatting this stigma surrounding gynaecologic cancer. Take a look at the list to see if there is an event near you! https://lnkd.in/eWf5qu8m #GOAgainstStigma #NoStigmainGO #WorldGODay #CervicalCancer #screening #ScreeningEquity #EndCervicalCancer #prevention #CervicalCancerAwareness #CervicalCancerFreeFuture With our partners: AUSL Reggio Emilia Babes-Bolyai University ECL Association of European Cancer Leagues European Institute of Women's Health, CLG Health Psychology Research Center IARC - International Agency for Research on Cancer / World Health Organization Inserm Transfert London School of Hygiene and Tropical Medicine, U. of London ISPUP | Instituto de Saúde Pública da Universidade do Porto Paris School of Economics Regionshospitalet Randers University of Tartu

France Asso Cancer et Peau a interviewé la Pr Lise Boussemart au sujet de sa nouvelle étude. L'objectif de son étude est d'optimiser les traitements des cancers en proposant des thérapies personnalisées, mieux adaptées aux patients, et de développer une approche permettant de prédire plus efficacement la réponse aux traitements. Pour en savoir plus sur son projet novateur, l'interview est ici ⤵ https://swll.to/WJTyJV

#AMCDiscoveries The National Lung Screening Trial (NLST) identified individuals at high risk for lung cancer and showed that serial low-dose helical computed tomography could identify lung cancer at an earlier stage, leading to mortality reduction. However, there is little evidence regarding the effectiveness of the NLST criteria for the Asian population. Researchers from Changi General Hospital (CGH) and SingHealth Residency performed a retrospective audit with the aim to describe the characteristics of patients diagnosed with lung cancer and to identify patients who would miss out on lung cancer screening when the NLST criteria was applied. They found that the majority of Singapore patients diagnosed with lung cancer, especially females, would not have been identified with the NLST criteria. However, those who met the inclusion criteria would have benefited greatly from screening. Extending the screening age upper limit may yield benefits and improved sensitivity in the Singapore context. Read more in SMJ, Wolters Kluwer: https://bit.ly/4byGYt8 AMC researchers involved: Sean Chee Hong Loh, Pearly Wenjia Koh, Daniel Jia Ming Ang, Lee W., Wui Mei Chew, Jansen Koh #AMRInews #research #Singapore #lungcancer #screening #nlst #CGH #SingHealth #AMC Visit SingHealth Duke-NUS AM Research Institute (AMRI) at https://for.sg/aboutamri